CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that is designed to stimulate the release of growth hormone (GH) from the pituitary gland. It is primarily used in research settings to explore its potential therapeutic applications in conditions related to growth hormone deficiencies and aging.